EU
AVEO

Emory University’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Emory University’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-60,288
Closed -$1.68M – 50
2017
Q4 		$1.68M Buy
+60,288
New +$1.87M 1.44% 37

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Emory University's AVEO Position: Q1 2018 in Review

Emory University sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2018, closing a stake of 60,288 shares — an estimated $1.68M sold.

Emory University first reported a position in AVEO in Q4 2017 and held it in 1 quarter. The position peaked at $1.68M in Q4 2017. 90 funds tracked by Wall St. Rank hold AVEO as of Q1 2018.

  • Emory University reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Emory University sold 60,288 AVEO Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1.68M.
  • Emory University first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
  • Emory University's AVEO Pharmaceuticals, Inc. position peaked at $1.68M in Q4 2017.
  • 90 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2018.

Based on Emory University's 13F filing for Q1 2018, filed 14 May 2018.